Open AccessClinical trials in geriatrics: actual status and international regulatory guidlines
Author(s) -
I. P. Malaya
Publication year - 2021
Publication title -
rossijskij žurnal geriatričeskoj mediciny
Language(s) - English
Resource type - Journals
eISSN - 2686-8709
pISSN - 2686-8636
DOI - 10.37586/2686-8636-1-2021-97-104
Subject(s) - geriatrics , clinical trial , medicine , gerontology , clinical research , population ageing , drug development , drug trial , population , polypharmacy , drug , intensive care medicine , environmental health , psychiatry
The number of old and very old people is increasing every year. Geriatric population is considered as the most growing age group. By different estimations about 60% of medicines are prescribed to patients of 65 and older. In the same time this age group is underrepresented in clinical trials. Participation of elderlies in clinical trials is really actual now and requires further development form regulatory authorities, drug manufactures and investigators. This review summarizes actual international guidelines on clinical trials in geriatric population.